Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:42 PM
Ignite Modification Date:
2025-12-24 @ 6:42 PM
NCT ID:
NCT05871957
Eligibility Criteria:
Inclusion Criteria:
* Meeting the diagnostic criteria of Hashimoto's thyroiditis in Western medicine (according to the Chinese Guidelines for the Diagnosis and Treatment of Thyroid Diseases - Thyroiditis and the Guidelines for the Diagnosis and Treatment of hypothyroidism in adults).
* Signing informed consent.
Exclusion Criteria:
* Patients with thyroid cancer;
* Other thyroid related diseases, such as Graves' disease;
* History of thyroid surgery or radioiodine therapy;
* Life history of iodine deficiency area with goiter;
* Immunosuppressive agents or immunomodulatory agents (mannan peptide, ubenamex, cyclophosphamide, incense) should be used within 1 month Polysaccharide, interferon, glucocorticoid, etc.); Other proprietary Chinese medicine (Bailing capsule, Prunella capsule, etc.)
* Patients taking chronic medications that may interfere with thyroid hormone or vitamin D metabolism;
* pregnancy plan during pregnancy or within six months;
* Severe liver and renal dysfunction;
* Serious systemic diseases, such as heart failure, stroke, and malignant tumors;
* With other autoimmune diseases: type 1 diabetes mellitus, systemic lupus erythematosus, rheumatoid arthritis, Vitiligo, autoimmune adrenal dysfunction;
* Those who are supplementing other trace elements;
* People allergic to vitamin D;
* Patients with hypercalcemia or other related diseases or mental disorders are unwilling to cooperate.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT05871957
Study Brief:
Protocol Section:
NCT05871957